DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, offering promising progress across a variety of professional medical and industrial programs. With its structural similarity to Normally derived human serum albumin, OsrHSA supplies a safer, extra trusted option for therapeutic use,